Betalgon

Contraindications

Hypersensitivity to the components of the drug.

Batallon® do not apply to the area of open wounds, as well as to irritated or damaged skin. It is not recommended to use the drug for the treatment of children without consulting a doctor.

Pharmaceutical form

The ointment is white in color or white with a shade from light yellow to light brown, with a specific smell.

Undesirable effects

Allergic reactions.

Special instructions

You should avoid getting Betalgon on the mucous membranes of the eyes, nose and mouth, as this causes a harmless but unpleasant burning sensation. Patients with sensitive skin it is not recommended to take a hot shower or bath before and after application Bataljona®. When applying too much Bataljona® its effect can be weakened by wiping the skin with a napkin soaked in vegetable oil or nourishing cream. After using Bataljona® hands should be thoroughly washed with soap and water.

Therapeutic indications

Muscle and joint pain.

Bruises and injuries of the musculoskeletal system.

Osteochondrosis of the spine with radicular syndrome.

Neuralgia, lumbago, sciatica.

Sports injuries.

Violations of the peripheral circulation.

Pharmacotherapeutic group

  • Local irritant agents in combinations

Pharmacodynamic properties

The effect occurs a few minutes after the use of the drug Betalgon® and reaches its maximum within 20-30 minutes.

Special precautions for storage

In a dry place, protected from light, at a temperature not exceeding 20 °C.

Keep out of reach of children.

The shelf life of the drug Batallon®2 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

Ointment for external use 100 g
beta-butoxyethyl ether of nicotinic acid 2.5 g
pelargonic acid vanillylamide 0.4 g
excipients: citral, purified water, beeswax, vaseline-up to 100 g  

in aluminum tubes of 15, 20 or 25 g, in a pack of cardboard 1 tube.

Fertility, pregnancy and lactation

With caution, it is prescribed during pregnancy and breastfeeding.

Nosological classification (ICD-10)

  • G54. 1 Lesions of the lumbosacral plexus
  • M05-M14 Inflammatory polyarthropathies
  • M25. 5 Joint pain
  • M42 Spinal osteochondrosis
  • M54 Dorsalgia
  • M54. 3 Sciatica
  • M54. 4 Lumbago with sciatica
  • M65 Synovitis and tendosynovitis
  • M71 Other bursopathies
  • M79. 1 Myalgia
  • M79. 2 Neuralgia and neuritis, unspecified
  • T14. 0 Superficial trauma to an unspecified area of the body
  • T14. 3 Dislocation, sprain and damage to the capsular ligamentous apparatus of the joint in an unspecified area of the body

Dosage (Posology) and method of administration

Externally. Application Bataljona should always start with very small amounts of the drug. To open the tube, the membrane in the tube head must be pierced with the tip of the cap. A column of the drug no more than 0.5 cm (the size of a pea) is applied with an applicator to the corresponding area of the skin the size of a palm. After applying Bataljona® you can enhance its therapeutic effect by covering this area of the skin with a woolen cloth (or something similar). Do not use the drug for more than 10 days without consulting a doctor.

ATC - Anatomical and therapeutic chemical classification

M02AX10 Other preparations